Your browser doesn't support javascript.
loading
Prediction of multiple sclerosis outcomes when switching to ocrelizumab.
Zhong, Michael; van der Walt, Anneke; Stankovich, Jim; Kalincik, Tomas; Buzzard, Katherine; Skibina, Olga; Boz, Cavit; Hodgkinson, Suzanne; Slee, Mark; Lechner-Scott, Jeannette; Macdonell, Richard; Prevost, Julie; Kuhle, Jens; Laureys, Guy; Van Hijfte, Liesbeth; Alroughani, Raed; Kermode, Allan G; Butler, Ernest; Barnett, Michael; Eichau, Sara; van Pesch, Vincent; Grammond, Pierre; McCombe, Pamela; Karabudak, Rana; Duquette, Pierre; Girard, Marc; Taylor, Bruce; Yeh, Wei; Monif, Mastura; Gresle, Melissa; Butzkueven, Helmut; Jokubaitis, Vilija G.
Affiliation
  • Zhong M; Central Clinical School, Monash University, Melbourne, VIC, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia.
  • van der Walt A; Central Clinical School, Monash University, Melbourne, VIC, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia.
  • Stankovich J; Central Clinical School, Monash University, Melbourne, VIC, Australia.
  • Kalincik T; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/MS Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Buzzard K; MS Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia/Department of Neurology, Box Hill Hospital, Melbourne, VIC, Australia/Monash University, Melbourne, VIC, Australia.
  • Skibina O; Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia/Department of Neurology, Box Hill Hospital, Melbourne, VIC, Australia/Monash University, Melbourne, VIC, Australia.
  • Boz C; KTU Medical Faculty, Farabi Hospital, Trabzon, Turkey.
  • Hodgkinson S; Liverpool Hospital, Sydney, NSW, Australia.
  • Slee M; Flinders University, Adelaide, SA, Australia.
  • Lechner-Scott J; School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia/Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, NSW, Australia.
  • Macdonell R; Department of Neurology, Austin Health, Melbourne, VIC, Australia.
  • Prevost J; CSSS Saint-Jérôme, Saint-Jérôme, QC, Canada.
  • Kuhle J; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Laureys G; Department of Neurology, University Hospital Ghent, Ghent, Belgium.
  • Van Hijfte L; Department of Neurology, University Hospital Ghent, Ghent, Belgium.
  • Alroughani R; Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait.
  • Kermode AG; Perron Institute, The University of Western Australia, Perth, WA, Australia/Institute of Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia.
  • Butler E; Monash Medical Centre, Melbourne, VIC, Australia.
  • Barnett M; Brain and Mind Centre, Sydney, NSW, Australia.
  • Eichau S; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • van Pesch V; Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
  • Grammond P; CISSS Chaudière-Appalache, Levis, QC, Canada.
  • McCombe P; Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
  • Karabudak R; Department of Neurology, Hacettepe University, Ankara, Turkey.
  • Duquette P; CHUM and Universite de Montreal, Montreal, QC, Canada.
  • Girard M; CHUM and Universite de Montreal, Montreal, QC, Canada.
  • Taylor B; Royal Hobart Hospital, Hobart, TAS, Australia.
  • Yeh W; Central Clinical School, Monash University, Melbourne, VIC, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia.
  • Monif M; Central Clinical School, Monash University, Melbourne, VIC, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia/MS Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Gresle M; Central Clinical School, Monash University, Melbourne, VIC, Australia.
  • Butzkueven H; Central Clinical School, Monash University, Melbourne, VIC, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia.
  • Jokubaitis VG; Central Clinical School, Monash University, Melbourne, VIC, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia.
Mult Scler ; 28(6): 958-969, 2022 05.
Article in En | MEDLINE | ID: mdl-34623947
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: Australia